GoodRx released a new report, 'The Prescription Drug Gender Divide,' detailing that women spent $8.8 billion, or 30%, more than men on out-of-pocket prescription costs in 2024. This highlights a significant financial disparity in healthcare.
The report suggests that this 'pink tax' in healthcare stems from higher healthcare utilization, increased rates of chronic conditions, and spending on female-specific conditions such as fertility and menopause treatments. This financial pressure can force women to make difficult choices regarding their health.
GoodRx is actively working to address this gender gap by offering savings on medications for female-specific conditions, including birth control, menopause treatments, and fertility medications. The company aims to help women save time and money when filling prescriptions at over 70,000 pharmacies nationwide.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.